Towards implementing exercise into the prostate cancer care pathway: development of a theory and evidence-based intervention to train community-based exercise professionals to support change in patient exercise behaviour (The STAMINA trial).
Androgen deprivation therapy
Behaviour change
Behaviour change wheel
Exercise
Exercise professionals
Intervention development
Medical Research Council
Patient and public involvement
Person based approach
Prostate cancer
Journal
BMC health services research
ISSN: 1472-6963
Titre abrégé: BMC Health Serv Res
Pays: England
ID NLM: 101088677
Informations de publication
Date de publication:
22 Mar 2021
22 Mar 2021
Historique:
received:
15
12
2020
accepted:
11
03
2021
entrez:
22
3
2021
pubmed:
23
3
2021
medline:
15
5
2021
Statut:
epublish
Résumé
The National Institute for Health and Care Excellence (NICE) recommend that men on androgen deprivation therapy (ADT) for prostate cancer should receive supervised exercise to manage the side-effects of treatment. However, these recommendations are rarely implemented into practice. Community-based exercise professionals (CBEPs) represent an important target group to deliver the recommendations nationally, yet their standard training does not address the core competencies required to work with clinical populations, highlighting a need for further professional training. This paper describes the development of a training package to support CBEPs to deliver NICE recommendations. Development of the intervention was guided by the Medical Research Council guidance for complex interventions and the Behaviour Change Wheel. In step one, target behaviours, together with their barriers and facilitators were identified from a literature review and focus groups with CBEPs (n = 22) and men on androgen deprivation therapy (n = 26). Focus group outputs were mapped onto the Theoretical Domains Framework (TDF) to identify theoretical constructs for change. In step two, behaviour change techniques and their mode of delivery were selected based on psychological theories and evidence to inform intervention content. In step three, the intervention was refined following delivery and subsequent feedback from intervention recipients and stakeholders. Six modifiable CBEPs target behaviours were identified to support the delivery of the NICE recommendations. Nine domains of the TDF were identified as key determinants of change, including: improving knowledge and skills and changing beliefs about consequences. To target the domains, we included 20 BCTs across 8 training modules and took a blended learning approach to accommodate different learning styles and preferences. Following test delivery to 11 CBEPs and feedback from 28 stakeholders, the training package was refined. Established intervention development approaches provided a structured and transparent guide to intervention development. A training package for CBEPs was developed and should increase trust amongst patients and health care professionals when implementing exercise into prostate cancer care. Furthermore, if proven effective, the development and approach taken may provide a blueprint for replication in other clinical populations where exercise has proven efficacy but is insufficiently implemented.
Sections du résumé
BACKGROUND
BACKGROUND
The National Institute for Health and Care Excellence (NICE) recommend that men on androgen deprivation therapy (ADT) for prostate cancer should receive supervised exercise to manage the side-effects of treatment. However, these recommendations are rarely implemented into practice. Community-based exercise professionals (CBEPs) represent an important target group to deliver the recommendations nationally, yet their standard training does not address the core competencies required to work with clinical populations, highlighting a need for further professional training. This paper describes the development of a training package to support CBEPs to deliver NICE recommendations.
METHODS
METHODS
Development of the intervention was guided by the Medical Research Council guidance for complex interventions and the Behaviour Change Wheel. In step one, target behaviours, together with their barriers and facilitators were identified from a literature review and focus groups with CBEPs (n = 22) and men on androgen deprivation therapy (n = 26). Focus group outputs were mapped onto the Theoretical Domains Framework (TDF) to identify theoretical constructs for change. In step two, behaviour change techniques and their mode of delivery were selected based on psychological theories and evidence to inform intervention content. In step three, the intervention was refined following delivery and subsequent feedback from intervention recipients and stakeholders.
RESULTS
RESULTS
Six modifiable CBEPs target behaviours were identified to support the delivery of the NICE recommendations. Nine domains of the TDF were identified as key determinants of change, including: improving knowledge and skills and changing beliefs about consequences. To target the domains, we included 20 BCTs across 8 training modules and took a blended learning approach to accommodate different learning styles and preferences. Following test delivery to 11 CBEPs and feedback from 28 stakeholders, the training package was refined.
CONCLUSION
CONCLUSIONS
Established intervention development approaches provided a structured and transparent guide to intervention development. A training package for CBEPs was developed and should increase trust amongst patients and health care professionals when implementing exercise into prostate cancer care. Furthermore, if proven effective, the development and approach taken may provide a blueprint for replication in other clinical populations where exercise has proven efficacy but is insufficiently implemented.
Identifiants
pubmed: 33745448
doi: 10.1186/s12913-021-06275-w
pii: 10.1186/s12913-021-06275-w
pmc: PMC7982309
doi:
Substances chimiques
Androgen Antagonists
0
Types de publication
Clinical Trial
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
264Références
Eur Urol. 2016 Apr;69(4):693-703
pubmed: 26632144
Ann Behav Med. 2014 Aug;48(1):7-16
pubmed: 24500078
PLoS One. 2018 May 3;13(5):e0196868
pubmed: 29723262
PLoS One. 2018 Jul 5;13(7):e0197606
pubmed: 29975707
N Engl J Med. 2020 Jun 4;382(23):e82
pubmed: 32240581
Int J Cancer. 2019 Apr 15;144(8):1941-1953
pubmed: 30350310
JAMA. 2005 Jul 13;294(2):238-44
pubmed: 16014598
Adv Physiol Educ. 2017 Jun 1;41(2):203-211
pubmed: 28377434
Appl Physiol Nutr Metab. 2011 Jul;36 Suppl 1:S232-65
pubmed: 21800944
Implement Sci. 2013 Feb 17;8:22
pubmed: 23414420
Eur Urol. 2014 May;65(5):865-72
pubmed: 24119318
Cancer. 2008 Jun 1;112(11 Suppl):2577-92
pubmed: 18428205
Cochrane Database Syst Rev. 2018 Sep 19;9:CD010192
pubmed: 30229557
BMJ. 2008 Sep 29;337:a1655
pubmed: 18824488
Implement Sci. 2017 Sep 6;12(1):111
pubmed: 28877746
Eur J Cancer Care (Engl). 2015 Sep;24(5):618-34
pubmed: 25630851
BJU Int. 2013 Apr;111(4):543-8
pubmed: 23351025
BMJ. 2015 Mar 19;350:h1258
pubmed: 25791983
Implement Sci. 2015 Sep 24;10:132
pubmed: 26404642
Eur J Cancer Care (Engl). 2018 Mar;27(2):e12795
pubmed: 29193416
J Cancer Surviv. 2019 Oct;13(5):815-828
pubmed: 31475306
Ann Behav Med. 2013 Aug;46(1):81-95
pubmed: 23512568
Sci Rep. 2018 May 30;8(1):8374
pubmed: 29849032
Implement Sci. 2009 Aug 07;4:50
pubmed: 19664226
Am J Community Psychol. 2008 Jun;41(3-4):327-50
pubmed: 18322790
Med Care. 2012 Mar;50(3):217-26
pubmed: 22310560
Implement Sci. 2017 Jun 21;12(1):77
pubmed: 28637486
Transl Behav Med. 2019 Jan 1;9(1):147-157
pubmed: 29506209
BMC Med. 2010 Oct 20;8:63
pubmed: 20961442
J Med Internet Res. 2015 Jan 30;17(1):e30
pubmed: 25639757
Implement Sci. 2017 Feb 23;12(1):25
pubmed: 28231840
Qual Saf Health Care. 2005 Feb;14(1):26-33
pubmed: 15692000
Trials. 2014 Jul 05;15:267
pubmed: 24996765
Eur Urol. 2015 May;67(5):825-36
pubmed: 25097095
BMJ Open. 2019 Aug 15;9(8):e029954
pubmed: 31420394
Implement Sci. 2012 Apr 24;7:37
pubmed: 22530986